Joen is the CEO of Hemcheck since May 2019. He previously worked as a management consultant at McKinsey & Company and Qvartz, where he mainly worked with the development of private and public healthcare organizations, both in Sweden and internationally. He holds a MSc from the Stockholm School of Economics. Joen Averstad owns 91,547 shares in Hemcheck.
Peter is head of sales and marketing, and deputy CEO, at HemCheck since 2018. He previously worked as a Country Manager at M Care AB and between 1993-2018 he worked as General Manager for Sarstedt AB, where he focused on products and instruments within laboratory medicine. Peter has a master’s degree in economy with a specialization in marketing and organization from the Gothenburg School of Economics. Peter Andersson owns 120,000 warrants and no shares in Hemcheck.